Metabolic enzymes and pathways for phosphatidylcholine and neurotransmitter synthesis

The metabolic enzymes and pathways for phosphatidylcholine and neurotransmitter synthesis represent a complex biochemical network essential for maintaining neuronal structural integrity and signaling. Phosphatidylcholine (PC) is the primary phospholipid in neuronal membranes and is synthesized mainly via the Kennedy pathway, which utilizes choline, cytidine, and fatty acids as primary substrates (Gibellini & Smith, 2010). Choline also serves as the direct precursor for acetylcholine, the primary neurotransmitter of the cholinergic system, synthesized by the enzyme choline acetyltransferase (Blusztajn & Wurtman, 1983). In neurodegenerative conditions like Alzheimer's disease, a shortage of these precursors can lead to "autocannibalism" of membrane phospholipids to maintain acetylcholine levels, resulting in synaptic loss and cognitive decline (Wurtman, 2009). Therapeutic strategies focus on administering precursor combinations, such as uridine and omega-3 fatty acids, to support the rate-limiting steps of these pathways and promote synaptogenesis (Sijben et al., 2011). This metabolic system is a critical focus for medical foods and supplements aimed at improving cognitive function and slowing brain atrophy in aging populations.

Other names

Kennedy pathwayCDP-choline pathwayPhospholipid biosynthetic pathwayAcetylcholine synthesis pathwayCholine metabolic pathway

Provision of rate-limiting precursors (choline, uridine, and omega-3 fatty acids) to increase the flux through the Kennedy pathway for phosphatidylcholine synthesis and the choline acetyltransferase reaction for acetylcholine production.